IGF1 and neoplasm: Specifically, ACRODAT® uses the 5 key parameters (IGF-1 levels, comorbidities presence, tumor status, symptoms and health-related quality of life) that have been identified as the best predictors of disease activity and are divided into categories that indicate severity.